Dos Santos Vanessa Tieko Marques, Mizukami Amanda, Orellana Maristela Delgado, Caruso Samia Rigotto, da Silva Fernanda Borges, Traina Fabiola, de Lima Prata Karen, Covas Dimas Tadeu, Swiech Kamilla
Center for Cell-Based Therapy, Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Transfus Med Hemother. 2017 Jan;44(1):11-21. doi: 10.1159/000448196. Epub 2016 Nov 2.
So far, using human blood-derived components appears to be the most efficient and safest approach available for mesenchymal stromal cell (MSC) expansion. In this paper, we report on the characterization of human AB serum (AB HS) produced by using different plasma sources, and its use as an alternative supplement to MSC expansion.
Two plasma sources were used for AB HS production: plasma removed from whole blood after 24 h of collection (PC > 24 h) and plasma, cryoprecipitate reduced (PCryoR). The biochemical profile and quality of the produced AB HS batches were analyzed and their ability to support MSC cell growth after different storage times (0, 3, 6, 9 and 12 months) was evaluated.
The two plasma sources used showed similar characteristics regarding biochemical constituents and quality parameters and were effective in promoting MSC growth. MSCs cultured in medium supplemented with 10% AB HS presented similar doubling times and cumulative population doublings when compared to the 10% fetal bovine serum(FBS)-supplemented culture while maintaining immunophenotype, functional features, and cytogenetic profile.
Overall, the results indicate that AB HS is an efficient FBS substitute and can be used for at least 12 months after production without impairing cell proliferation and quality.
到目前为止,使用人血衍生成分似乎是间充质基质细胞(MSC)扩增最有效和最安全的方法。在本文中,我们报告了使用不同血浆来源生产的人AB血清(AB HS)的特性,以及将其用作MSC扩增替代补充剂的情况。
使用两种血浆来源生产AB HS:采集24小时后从全血中分离的血浆(PC > 24 h)和冷沉淀减少的血浆(PCryoR)。分析所生产的AB HS批次的生化特征和质量,并评估其在不同储存时间(0、3、6、9和12个月)后支持MSC细胞生长的能力。
所使用的两种血浆来源在生化成分和质量参数方面表现出相似的特征,并且在促进MSC生长方面有效。与补充10%胎牛血清(FBS)的培养基培养的MSC相比,在补充10% AB HS的培养基中培养的MSC具有相似的倍增时间和累积群体倍增数,同时保持免疫表型、功能特征和细胞遗传学特征。
总体而言,结果表明AB HS是一种有效的FBS替代品,生产后至少可使用12个月而不损害细胞增殖和质量。